People Background Check
Find People:

John H Tatlock, Age 5711634 Compass Point Dr N UNIT 114, San Diego, CA 92126

Get Report
Known as:
John Howard Tatlock John M Tatlock Kimberly A Tatlock
Related to:
Clare E Labatti 24

John Tatlock Phones & Addresses

San Marcos, CA

13153 Dressage Ln, San Diego, CA 92130 (858) 755-8893

Prescott, AZ

1926 White Birch Dr, Vista, CA 92083

Schenectady, NY

Del Mar, CA

Poway, CA

10220 Camino San Thomas, San Diego, CA 92127

Show more

Social networks

John H Tatlock

Linkedin

Work

Company: Pfizer Feb 1990 Position: Associate research fellow

Skills

Drug Discovery • Drug Design • Medicinal Chemistry • Chemistry • Organic Synthesis

Emails

k***[email protected]

Industries

Pharmaceuticals

Mentions for John H Tatlock

John Tatlock resumes & CV records

Resumes

John Tatlock Photo 11

Associate Research Fellow

Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Pfizer
Associate Research Fellow
Skills:
Drug Discovery, Drug Design, Medicinal Chemistry, Chemistry, Organic Synthesis

Publications & IP owners

Us Patents

Compounds, Pharmaceutical Compositions, And Methods For Stimulating Neuronal Growth And Elongation

US Patent:
6630472, Oct 7, 2003
Filed:
Jul 16, 1999
Appl. No.:
09/356240
Inventors:
Susumu Katoh - Osaka, JP
Hiroshi Kawakami - Osaka, JP
Hiroki Tada - Osaka, JP
Maria Angelica Linton - San Diego CA
Vincent Kalish - Annapolis MD
John Howard Tatlock - Vista CA
Jesus Ernesto Villafranca - San Diego CA
Assignee:
Pfizer Inc - New York NY
International Classification:
C07D47118
US Classification:
514249, 540520, 544343, 544346, 544349
Abstract:
Compounds that inhibit the peptidyl-prolyl isomerase (rotamase) enzyme activity of the FK-506 binding protein (FKBP) and compositions comprising these compounds are described. The FKBP-inhibiting compounds have a bicyclic [3. 3. 1], [4. 3. 1] or polycyclic azaamide nucleus. Pharmaceutical compositions containing such compounds help stimulate the outgrowth of neurites in nerve cells and augmenting nerve regeneration. Methods of treating nerve cells with such compositions are useful to promote repair of neuronal damage caused by disease and physical trauma.

Hiv Protease Inhibitors, Compositions Containing The Same, Their Pharmaceutical Uses And Materials For Their Synthesis

US Patent:
6953858, Oct 11, 2005
Filed:
Jun 11, 2002
Appl. No.:
10/166957
Inventors:
Stacie S. Canan Koch - La Jolla CA, US
Therese N. Alexander - San Diego CA, US
Mark Barvian - Ann Arbor MI, US
Gary Bolton - Ann Arbor MI, US
Benjamin J. Burke - San Diego CA, US
Tod Holler - Ann Arbor MI, US
Tanya M. Jewell - Encinitas CA, US
Vara Prasad Josyula - Ann Arbor MI, US
David J. Kucera - Del Mar CA, US
Maria Angelica Linton - San Diego CA, US
Jeffrey J. Machak - Shelby Township MI, US
Sean T. Murphy - Ypsilanti MI, US
Siegfried H. Reich - Solana Beach CA, US
Donald J. Skalitzky - San Diego CA, US
John H. Tatlock - San Diego CA, US
Michael D. Varney - Solana Beach CA, US
Scott C. Virgil - San Diego CA, US
Stephen E. Webber - San Diego CA, US
Stephen T. Worland - Del Mar CA, US
Michael Melnick - Ann Arbor MI, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D277/06
US Classification:
548200
Abstract:
Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase

US Patent:
7115658, Oct 3, 2006
Filed:
May 9, 2003
Appl. No.:
10/434702
Inventors:
Allen J. Borchardt - San Diego CA, US
Peter Scott Dragovich - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Ru Zhou - Carlsbad CA, US
Thomas Jay Prins - Cardiff CA, US
Melwyn A. Abreo - Jamul CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/351
US Classification:
514460, 514459, 514336, 514365, 514452, 514364, 514378, 514405, 514326, 5142315, 514422, 51425931, 514384, 514397, 5142621, 514456, 5142581, 514382, 51425505, 514369, 514274, 514340, 514363, 514375, 5142541
Abstract:
Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7148226, Dec 12, 2006
Filed:
Nov 19, 2003
Appl. No.:
10/718337
Inventors:
Allen Borchardt - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - Linton CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/519
US Classification:
5142591, 514397, 514378, 514394, 5142631, 51426323, 514406, 514414, 514383, 544264, 544278, 5482632, 5482642, 5483047, 5483657
Abstract:
The invention relates to compounds of the formula 1.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7151105, Dec 19, 2006
Filed:
Aug 15, 2005
Appl. No.:
11/204269
Inventors:
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/519
A61K 31/35
A01N 43/90
A01N 43/16
C07D 487/00
US Classification:
51425931, 544263, 514460, 549292
Abstract:
The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).

Hiv Protease Inhibitors, Compositions Containing The Same, Their Pharmaceutical Uses And Materials For Their Synthesis

US Patent:
7179918, Feb 20, 2007
Filed:
Jun 11, 2002
Appl. No.:
10/166979
Inventors:
Stacie S. Canan Koch - La Jolla CA, US
Therese N. Alexander - San Diego CA, US
Benjamin J. Burke - San Diego CA, US
Tanya M. Jewell - Encinitas CA, US
David J. Kucera - Del Mar CA, US
Maria Angelica Linton - San Diego CA, US
Siegfried H. Reich - Solana Beach CA, US
Donald J. Skalitzky - San Diego CA, US
John H. Tatlock - San Diego CA, US
Michael D. Varney - Solana Beach CA, US
Scott C. Virgil - San Diego CA, US
Stephen E. Webber - San Diego CA, US
Stephen T. Worland - Del Mar CA, US
Mark Barvian - Ann Arbor MI, US
Gary Bolton - Ann Arbor MI, US
Jeffrey J. Machak - Shelby Township MI, US
Tod Holler - Ann Arbor MI, US
Sean T. Murphy - Ypsilanti MI, US
Michael Melnick - Ann Arbor MI, US
Vara Prasad Josyula - Ann Arbor MI, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 207/16
C07D 221/02
US Classification:
546112, 546146, 548540, 514423
Abstract:
Compounds of the formula:.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7473790, Jan 6, 2009
Filed:
May 8, 2006
Appl. No.:
11/382154
Inventors:
Allen Borchardt - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 309/30
C07D 305/00
C07D 309/00
US Classification:
549291, 549263, 549273
Abstract:
The invention relates to compounds of the formula 1.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7622605, Nov 24, 2009
Filed:
Sep 6, 2006
Appl. No.:
11/470540
Inventors:
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07C 69/34
C07C 69/52
US Classification:
560190
Abstract:
The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).

Isbn (Books And Publications)

Mind And Art Of Chaucer

Author:
John Tatlock
ISBN #:
0877521093

Modern Reader'S Chaucer

Author:
John S. Tatlock
ISBN #:
0029324106

Development And Chronology Of Chaucer'S Works

Author:
John S. Tatlock
ISBN #:
0935005803

Possible Relatives

Jason Tatlock  Lorraine S Tatlock  Mark D Tatlock  Robert K Tatlock  Sandra K Tatlock  Veronica M Tatlock  John J Last  John J Stan  John C Stanaway  John B Stanbro 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.